< Back to the Blog
About the author

Dr. Aparna (Amy) Divaraniya is the Founder and CEO of Oova. She has over 10 years experience working in data science and a PhD in Biomedical Sciences. In 2017, Amy pivoted to women's healthcare after facing her own fertility struggles. Amy started Oova to give women control over their fertility by making high-quality hormone testing more accessible.
Sources
Information based on presentations at the American Society for Reproductive Medicine 2025 Meeting, October 25-29, 2025, San Antonio, TX.
- ASRM 2025 Scientific Congress & Expo. American Society for Reproductive Medicine, 25-29 Oct. 2025, San Antonio, TX.
- Chian, Ri-Cheng, et al. "The Quality of Human Eggs and Its Pre-IVF Incubation." Reproductive Medicine and Biology, vol. 24, 2025, doi:10.1002/rmb2.12652.
- "IVF Success Rates in 2025: Latest Research and Clinical Evidence." The Wellness London, 4 Sept. 2025.
- "Mosaic Embryo Transfer versus Additional IVF with PGT-A Cycle." Journal of Assisted Reproduction and Genetics, 2024.
- Zurera-Egea, Coral, et al. "The Utility of Sperm DNA Fragmentation as a Diagnostic Tool for Male Infertility." International Journal of Molecular Sciences, vol. 26, no. 13, 2025.
About the Oova Blog:
Our content is developed with a commitment to high editorial standards and reliability. We prioritize referencing reputable sources and sharing where our insights come from. The Oova Blog is intended for informational purposes only and is never a substitute for professional medical advice. Always consult a healthcare provider before making any health decisions.



